找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Developments in Statistical Evaluation of Clinical Trials; Kees van Montfort,Johan Oud,Wendimagegn Ghidey Book 2014 Springer-Verlag Berlin

[復制鏈接]
樓主: deferential
51#
發(fā)表于 2025-3-30 10:57:25 | 只看該作者
Mindfulness in Behavioral Healthharmacokinetic exposure-response relationship and (2) dose-response relationship when dose-adjustment depends on potential responses. Dose adjustment often happens in clinical trials either designed for therapeutic dose monitoring, or spontaneously due to, for example, adverse events. It makes causa
52#
發(fā)表于 2025-3-30 14:04:30 | 只看該作者
Realistic Random Direction Mobilityrement. For a continuous outcome variable, a classical GLM for repeated measurements can be used to analyse the difference in development over time between the intervention and control group. However, because GLM for repeated measurements has some major disadvantages (e.g., only suitable for complet
53#
發(fā)表于 2025-3-30 18:28:08 | 只看該作者
54#
發(fā)表于 2025-3-30 22:09:12 | 只看該作者
55#
發(fā)表于 2025-3-31 02:13:43 | 只看該作者
Handbook of Mobile Data Privacycal trials. However, failed past attempts to use surrogate endpoints made it clear that, before deciding on the use of a candidate surrogate endpoint, it is of the utmost importance to investigate its validity. Such validation process has proven challenging for conceptual and practical reasons. In t
56#
發(fā)表于 2025-3-31 08:27:38 | 只看該作者
Handbook of Mobile Data Privacycularly, in oncology. This chapter provides an overview of various biomarker-based designs for phase III randomized clinical trials to evaluate clinical utility of a biomarker or biomarker-based treatment, including biomarker-strategy, enrichment, and randomize-all designs. We also provide a simulat
57#
發(fā)表于 2025-3-31 11:16:09 | 只看該作者
Handbook of Mobile Teaching and Learning such as the continual reassessment method (CRM), have been gradually applied to single-agent trials to determine the maximum tolerated dose (MTD). By contrast, the rule-based approaches have commonly been applied to two-agent combination trials, probably due to the absence of well-understood model-
58#
發(fā)表于 2025-3-31 15:33:15 | 只看該作者
Handbook of Mobile Teaching and Learningally in first or second line of cancer therapies. Basic formulae for the determination of sample sizes based on time to event data can be found in the literature. Assumptions about the distributions of the survival time for OS and PFS, the accrual time and the censoring time are of key importance. M
59#
發(fā)表于 2025-3-31 18:29:15 | 只看該作者
60#
發(fā)表于 2025-4-1 01:44:21 | 只看該作者
Marcello Farina,Riccardo Scattolinid as the dose associated with a certain probability of dose limiting toxicity (DLT) during the first cycle of treatment, although toxicity is repeatedly measured over cycles on an ordinal scale. We present the main dose finding methods developed in the era of cytotoxic agents. We illustrate their pr
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-30 12:29
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
永顺县| 阿拉善左旗| 大厂| 巨鹿县| 赤峰市| 临夏县| 博罗县| 昌邑市| 乌什县| 临澧县| 当涂县| 清水县| 阳江市| 临泽县| 凤阳县| 长葛市| 银川市| 连江县| 武功县| 琼海市| 乌鲁木齐市| 静宁县| 静安区| 巴中市| 庐江县| 瓮安县| 邯郸市| 犍为县| 历史| 绥棱县| 沂南县| 建水县| 沙河市| 桐柏县| 古丈县| 溆浦县| 沂水县| 云梦县| 精河县| 满洲里市| 措美县|